FDA Revises Trial Requirements for Drug and Medical Product Approval
Neurology® Podcast · Mar 31, 2026 · 14:42
Neurology® Podcast · Mar 31, 2026 · 14:42
Listen in the Podli app 🎧
Follow your favourite podcasts, listen offline and in the car with CarPlay and Android Auto, and always pick up where you left off. Free to try.
Dr. Justin Abbatemarco talks with Lizzy Lawrence about the FDA's shift toward single-trial drug approvals and its implications for neurology, rare diseases, and broader effects on drug approval standards and healthcare access.
Read the related article on STAT News.
Disclosures can be found at Neurology.org.
